About the Company
Gilead Sciences, Inc. () is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Gilead is a member of the Nasdaq-100 and the S&P 100. Gilead was founded in 1987 under the name Oligogen by Michael L. Riordan. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs like Tamiflu and Vistide that decade. In the 2000s, Gilead received approval for drugs including Viread and Hepsera, among others. It began evolving from a biotechnology company into a pharmaceutical company, acquiring several subsidiaries, though it still relied heavily on contracting to manufacture its drugs. The company continued its growth in the 2010s. However, it came under heavy scrutiny over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on GILEAD SCIENCES, INC.
GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo
Gilead shares slip after CVS refused to add its new HIV drug, Yeztugo, while its Kite unit struck a $350 million deal with ...
Gilead Sciences CEO Says HIV Prevention Drug Offers Clear Value
Gilead Sciences Inc. Chief Executive Officer Daniel O’Day said the company’s new HIV prevention drug Yeztugo should be able ...
Gilead Sciences (GILD) Touches New Record High as 10 Analysts Turn Bullish
We recently published 10 Stocks with Eye-Popping Gains; 5 Jump to New Highs. Gilead Sciences, Inc. (NASDAQ:GILD) is one of ...
Is Trending Stock Gilead Sciences, Inc. (GILD) a Buy Now?
Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
Gilead Sciences to Present at Upcoming Investor Conferences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to ... - Nasdaq
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It April 03, 2024 — 09:00 am EDT Written by Zacks Equity Research for Zacks -> ...
How To Earn $500 A Month From Gilead Sciences Stock Ahead Of Q2 Earnings
Gilead Sciences, Inc. (NASDAQ:GILD) will release earnings results for the second quarter, after the closing bell on Thursday, ...
Gilead Sciences, Inc. (GILD) Hits Fresh High: Is There Still ... - Nasdaq
Gilead Sciences has gained 24.2% since the start of the year compared to the 6% move for the Zacks Medical sector and the 6% return for the Zacks Medical - Biomedical and Genetics industry.
Gilead Sciences Ranked in Top Five Most Just List for
Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives ...
Gilead Sciences to Present at Upcoming Investor Conference
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.
Similar Companies
Loading the latest forecasts...